At Centerline Biomedical, our mission is to advance the standard of care for minimally invasive endovascular procedures, leading to more efficient, more accurate and safer procedures resulting in improved patient outcomes.
Founded in 2014 as a spinoff of the Cleveland Clinic, Centerline Biomedical is a result of a collaboration between surgeons at the Miller Family Heart & Vascular Institute, the #1 ranked heart program in the U.S. and researchers at Lerner Research Institute. The brainchild of Vikash Goel, currently Chief Technology Officer of Centerline, and Karl West, Director of Medical Devices at the Cleveland Clinic; IOPS was developed as a project inspired by their mentor and friend, renowned vascular surgeon and innovator Dr. Roy K. Greenberg. Dr. Greenberg sadly passed away in December 2013 after a battle with cancer. He was instrumental in the acceptance of Endovascular Aortic Repair (EVAR) as an alternative to open surgery, and one of the surgeons performing the greatest number of these procedures. Dr. Greenberg’s illness was a key motivating factor in the development of IOPS.